-

Humana Names Dr. Shantanu Nundy as Chief Medical Officer

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. A practicing physician, healthcare executive, and technology leader, Dr. Nundy has spent his career using technology to make care better, simpler, and more human. At Humana, he will bring an innovative clinical voice to the enterprise and help shape the design of the company's products, platforms, and use of AI. Dr. Nundy will report to Jim Rechtin, Humana President and CEO, and will serve as a member of the company’s Enterprise Leadership Team.

“Clinical excellence is at the heart of Humana’s vision to be a leading consumer healthcare company, and I am thrilled to welcome Dr. Nundy as our new chief medical officer,” said Jim Rechtin, Humana President and CEO. “I am confident Shantanu’s experience at the intersection of clinical outcomes, technology, and the consumer experience will advance our efforts to simplify the path to care and help the people we serve achieve their best health.”

Dr. Nundy most recently served as Executive Vice President of Care Delivery and Chief Health Officer at Accolade, a personalized healthcare navigation and care delivery company serving millions of Americans, where he led a technology-driven transformation of the member care experience. Previously, he was Managing Director for Clinical Innovation at Evolent Health, where he drove value-based and digital care transformation across large health systems. He has advised a wide range of organizations on digital health and AI, including the U.S. Food and Drug Administration, World Bank, and a number of health technology startups. Dr. Nundy is a hands-on clinician who practices primary care at a community health center and hospital medicine at a regional health system. He is the author of two books and serves on the adjunct faculty at Stanford Medicine and Johns Hopkins Carey Business School. He earned his bachelor's degree from the Massachusetts Institute of Technology, his medical degree from Johns Hopkins and his MBA from the University of Chicago.

About Humana

Humana is a leading U.S. healthcare company. Through our Humana insurance services, and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

Contacts

Investors: Lisa Stoner - Humana Investor Relations; (502) 580-2652;
lstamper@humana.com

Media: Mark Taylor - Humana Corporate Communications; (317) 753-0345;
MTaylor108@humana.com

Humana Inc.

NYSE:HUM

Release Versions

Contacts

Investors: Lisa Stoner - Humana Investor Relations; (502) 580-2652;
lstamper@humana.com

Media: Mark Taylor - Humana Corporate Communications; (317) 753-0345;
MTaylor108@humana.com

More News From Humana Inc.

Humana Elects Paul Smith and Frederick Crawford to Board of Directors

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that the Company’s Board of Directors has elected Paul Smith and Frederick Crawford as new Board members, effective immediately. Smith is the Chief Commercial Officer at Anthropic, PBC where he leads commercial strategy and global go-to-market operations as the company scales to meet growing enterprise demand worldwide. He brings over 30 years of experience leading global go-to-market organizations through major technolog...

Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2026 (2Q26) versus the quarter ended June 30, 2025 (2Q25) and for the six months ended June 30, 2026 (YTD 2026) versus the six months ended June 30, 2025 (YTD 2025) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) In millions 2Q26 (a) 2Q25 (a) YTD 2026 (a) YTD 2025 (...

Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 2Q26 earnings call may be accessed via Humana’s Investor Relations page at h...
Back to Newsroom